1. Mulens, V., de la Torre, A., Marinello, P., Rodriguez, R., Cardoso, J., Diaz, R., O’Farrill, M., Macias, A., Viada, C., Saurez, G., Carr, A., Crombet, T., Mazorra, Z., Perez, R., Fernandez, L.E.: Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: results from a controlled study in metastatic breast cancer patients. Hum. Vaccin. 6 (9) (2010). doi:10.4161.hv.6.9.12571.
2. Alfonso, M., Vázquez, A.M., Carr, A., Haerslev, T., Fernández, L.E., Lanio, M.E., Alvarez, C., Zeuthen, J., Pe`rez, R., 1995. T cell-independent B cell response to self monosialogangliosides: primary response monoclonal antibodies. Hybridoma 14, 209–216.
3. Alfonso, M., Díaz, A., Hernández, A.M., Pérez, A., Rodríguez, E., Bitton, R., Pérez, R., Vázquez, A.M. An anti-idiotype vaccine elicits a specific response to N-glycolyl sialic acid residues of glycoconjugates in melanoma patients. J. Immunol. 2002; 168; 2523-2529.
4. Oliva, J.P., Valdés, Z., Casacó, A., Pimentel, G., González, J., Álvarez, I. et al. Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99m)Tc. Breast Cancer Res. Treat. 2006; 96 (2); 115-121.
5. Carr, A., Mullet, A., Mazorra, Z., Vázquez, A.M., Alfonso, M., Mesa, C., Rengifo, E., Pérez, R., Fernández, L.E.: A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors. Hybridoma 2000; 19 (3): 241-247. doi:10.1089/02724570050109639.
6. Carr, A., Mesa, C., del Carmen Arango, M., Vázquez, A.M., Fernández, L.E. In vivo and in vitro anti-tumor effect of 14F7 monoclonal antibody. Hybrid. Hybridomics 2002; 21 (6): 463-468.
7. Blanco R., Blanco D., Quintana Y., Escobar X., Rengifo C.E, Osorio M., Gutiérrez Z., Lamadrid J., Cedeño M., Frómeta M., Carr A. and Rengifo E. Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis. Pathology Research International Volume 2013, Article ID 920972, http://dx.doi.org/10.1155/2013/920972.
8. Roque-Navarro, L., Chakrabandhu, K., de Leon, J., Rodríguez, S., Toledo, C., Carr, A., de Acosta, C.M., Hueber, A.O., Pérez, R.: Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity. Mol. Cancer Ther. 7(7), 2033–2041 (2008). doi:10.1158/1535-7163.MCT-08-0222.